Tag: CSE:GSTR

January 12, 2021

Psychedelics Stocks to Watch

A growing list of the available psychedelics stocks to watch out for from the Investing News Network.
August 28, 2020

GreenStar Biosciences: A Leader in Transformational Medicine

GreenStar Biosciences (CSE:GSTR, OTC Pink:GTSIF) has launched their campaign on the Investing News Network's life science channel.
August 17, 2020

GreenStar Biosciences Announces Private Placement and Corporate Update

GreenStar Biosciences is pleased to announce that it has engaged Australian boutique brokerage firm, Peak Asset Management to act as...
July 27, 2020

GreenStar Biosciences Completes Acquisition of 100 Percent of Eleusian Biosciences Corp. and Appoints Jonathan Gilbert to Board of Directors and Maghsoud Dariani as Chief Science Officer

Strategic acquisition by GreenStar adds innovative company focused on the development of effective therapeutics using psychedelic medicine
July 23, 2020

GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences

Additional provisional patent application, strengthens IP portfolio of therapeutics for the treatment of mild traumatic brain injuries (mTBI) with PTSD...
July 21, 2020

GreenStar Biosciences Signs Definitive Agreement to Acquire 100% of Eleusian Biosciences Corp.

GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) has signed a definitive binding share exchange agreement dated July 20, 2020...
June 29, 2020

Aussie Investors Get a Taste for Psychedelics Market

Peak Asset Management hosted an online forum for investors to learn about the opportunity attached to Australia's psychedelics sector.